Related references
Note: Only part of the references are listed.Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients Time to Move Forward
Fernando J. Martinez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
Ahmed J. Yousuf et al.
LANCET RESPIRATORY MEDICINE (2022)
IL-33 in COPD: the hunt for responder subgroups
Dave Singh
LANCET RESPIRATORY MEDICINE (2022)
Blood Eosinophils and Chronic Obstructive Pulmonary Disease A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review
Dave Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
Andrew Higham et al.
ALLERGY (2021)
The role of FeNO in stable COPD patients with eosinophilic airway inflammation
Stefanie Vincken et al.
RESPIRATORY MEDICINE (2021)
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
Klaus F. Rabe et al.
LANCET RESPIRATORY MEDICINE (2021)
Exhaled nitric oxide: A biomarker for chronic obstructive pulmonary disease
Seiichi Kobayashi et al.
RESPIRATORY INVESTIGATION (2021)
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
Leena George et al.
ALLERGY (2020)
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
Gerard J. Criner et al.
LANCET RESPIRATORY MEDICINE (2020)
Effects of Lung Function-Related Genes and TSLP on COPD Phenotypes
Hideyasu Yamada et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD
Xiaoqian Liu et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
Dave Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Pharmacologic Management of Chronic Obstructive Pulmonary Disease An Official American Thoracic Society Clinical Practice Guideline
Linda Nici et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
Bin Tang et al.
MEDICAL SCIENCE MONITOR (2020)
Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD
Balazs Antus et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Aiyuan Zhou et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies
Chantal Donovan et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Detection of type2 biomarkers for response in COPD
Yoshikazu Yamaji et al.
JOURNAL OF BREATH RESEARCH (2020)
Benralizumab for the Prevention of COPD Exacerbations
G. J. Criner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
Jeanne Allinne et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Alvar Agusti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Bartolome R. Celli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
Patrizia Pignatti et al.
RESPIRATORY RESEARCH (2019)
Blood Eosinophilia Neither Reflects Tissue Eosinophils nor Worsens Clinical Outcomes in Chronic Obstructive Pulmonary Disease
Graziella Turato et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease Pooled Analysis of Two Randomized Trials
Fernando J. Martinez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD
Bernardino Alcazar-Navarrete et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles
Michael A. Ghebre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Viral induced overproduction of epithelial TSLP: Role in exacerbations of asthma and COPD?
Lena Uller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Alberto Papi et al.
LANCET (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Zhiyu Lu et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
Klaus F. Rabe et al.
LANCET RESPIRATORY MEDICINE (2018)
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
Gary T. Ferguson et al.
LANCET RESPIRATORY MEDICINE (2018)
Treatment of chronic obstructive pulmonary disease in patients with different fractional exhaled nitric oxide levels
Yao-Kuang Wu et al.
MEDICINE (2018)
Oxidative stress enhances the expression of IL-33 in human airway epithelial cells
Hiroyuki Aizawa et al.
RESPIRATORY RESEARCH (2018)
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Peter J. Barnes
NATURE REVIEWS IMMUNOLOGY (2018)
Serum periostin does not reflect type 2-driven inflammation in COPD
O. A. Carpaij et al.
RESPIRATORY RESEARCH (2018)
The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD
Damian Tworek et al.
RESPIRATORY RESEARCH (2018)
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Ciro Casanova et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts
Umme Kolsum et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
Jorgen Vestbo et al.
LANCET (2017)
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
I. D. Pavord et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
Jie Gao et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease
Sei Won Kim et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
Annette T. Hastie et al.
LANCET RESPIRATORY MEDICINE (2017)
Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
Umme Kolsum et al.
RESPIRATORY RESEARCH (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients
Hye Yun Park et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease The Copenhagen General Population Study
Signe Vedel-Krogh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort
Rachael L. DiSantostefano et al.
RESPIRATORY MEDICINE (2016)
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells
M. Contoli et al.
ALLERGY (2015)
Increased IL-33 expression in chronic obstructive pulmonary disease
Jie Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Asthma-COPD Overlap
Stephanie A. Christenson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Economic Burden of COPD in the Presence of Comorbidities
David M. Mannino et al.
CHEST (2015)
COPD comorbidities network
Miguel J. Divo et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts
Guy G. Brusselle et al.
LANCET RESPIRATORY MEDICINE (2015)
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
Steven Pascoe et al.
LANCET RESPIRATORY MEDICINE (2015)
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Exhaled Nitric Oxide Predicts Eosinophilic Airway Inflammation in COPD
Kun-Ta Chou et al.
LUNG (2014)
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Antonino Di Stefano et al.
THORAX (2014)
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2014)
Addressing unmet needs in the treatment of COPD
Francesco Patalano et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease
Derek E. Byers et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?
Vanessa M. McDonald et al.
THORAX (2013)
Comorbidities of COPD
Arnaud Cavailles et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Miguel Divo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Function and mechanisms of TSLP/TSLPR complex in asthma and COPD
N. S. Redhu et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Identification of Biologic Clusters and Their Biomarkers
Mona Bafadhel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Involvement of IL-13 in Tobacco Smoke-Induced Changes in the Structure and Function of Rat Intrapulmonary Airways
Philip R. Cooper et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Exhaled Nitric Oxide in Pulmonary Diseases A Comprehensive Review
Peter J. Barnes et al.
CHEST (2010)
Interleukin-13: prospects for new treatments
C. E. Brightling et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Thymic Stromal Lymphopoietin in Cigarette Smoke-Exposed Human Airway Smooth Muscle
Dan F. Smelter et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2009)
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Peter M. A. Calverley et al.
LANCET (2009)
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
W. Brett Cherry et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The cytokine network in asthma and chronic obstructive pulmonary disease
Peter J. Barnes
JOURNAL OF CLINICAL INVESTIGATION (2008)
Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease
Sun Ying et al.
JOURNAL OF IMMUNOLOGY (2008)
Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells
Vinod Suresh et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
Shawn D. Aaron et al.
ANNALS OF INTERNAL MEDICINE (2007)
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
R Leigh et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema
T Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease
A Papi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
